4880 — CellSource Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapFalling Star

Annual income statement for CellSource Co, fiscal year end - October 31st, JPY millions except per share, conversion factor applied.

	2021 October 31st	2022 October 31st	2023 October 31st	2024 October 31st	2025 October 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	2,922	4,274	4,511	4,355	3,711
Cost of Revenue
Gross Profit	2,074	3,064	3,185	2,417	2,087
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	1,930	2,712	3,280	4,214	3,603
Operating Profit	992	1,562	1,230	141	109
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	1,006	1,584	1,240	295	110
Provision for Income Taxes
Net Income After Taxes	651	1,018	923	238	10.7
Net Income Before Extraordinary Items
Net Income	651	1,018	923	238	10.7
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	651	1,018	923	238	10.7
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	33.9	53.3	47.6	11.3	2.38
Dividends per Share
Special Dividends per Share